-
Signature
-
/s/ Michelle Gilson, as Attorney-in-Fact
-
Stock symbol
-
ACLX
-
Transactions as of
-
Feb 7, 2024
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
2/9/2024, 04:05 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ACLX |
Common Stock |
Options Exercise |
$0 |
+70.2K |
+116.64% |
$0.00 |
130K |
Feb 7, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ACLX |
Restricted Stock Unit |
Options Exercise |
$0 |
-70.2K |
-50% |
$0.00 |
70.2K |
Feb 7, 2024 |
Common Stock |
70.2K |
|
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President, CEO and Chairman of the Board